WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 4'8001 Infant (under 12 months) mortality rate: 62
GDP / capita (US$): 11'8021 Child (under 5 years) mortality rate: 72

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 2'107  2'106  2'104  2'102  2'101  2'052  2'010  1'896 
Births 23  23  23  23  23  26  36  41 
Surviving infants 22  22  23  23  23  25  34  38 
Pop. less than 5 years 112  112  113  114  116  129  172  192 
Pop. less than 15 years 352  355  360  366  374  459  526  556 
Female 15-49 years 534  537  539  541  542  529  515  492 

Number of reported case

(Click for retrospective incidence data for The former Yugoslav Republic of Macedonia)
Diphtheria
Japanese encephalitis
Measles 701  217  36 
Mumps 60  97  111  242  10'920  441 
Pertussis 21 
Polio*
Rubella 11  87 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for The former Yugoslav Republic of Macedonia)
Vaccine year result method % card seen                                                
BCG 2009  98  MICS   89  97  95  94  98  97 
DTP1 2009  98  MICS   89  97  98  97  98 
DTP3 2009  95  MICS   89  98  95  96  95  96  95 
HepB_BD          98  99  97 
HepB3          97  98  96  90  95 
Hib3 2009  95  MICS   89  97  95  96  89  82 
JapEnc         
MCV 2009  96  MICS   89  96  96  97  98  96  97 
MCV2          96  96  98  99  97  95 
PCV1         
PCV3         
Pol3 2009  97  MICS   89  98  97  97  95  96  96 
Rota1         
Rota_last         
Rubella1          96  96  98  96 
TT2plus          86  94 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for The former Yugoslav Republic of Macedonia)
BCG 97  95  94  96  98  97 
DTP1 99  98  97  97  96  98 
DTP3 98  95  96  95  96  95 
HepB3 97  98  96  90  95 
HepB_BD 98  99  97  95  93 
Hib3 97  95  96  89  82 
MCV 96  96  97  98  96  97 
MCV2 96  96  98  99  97  95 
PnC3
Pol3 98  97  97  95  96  96 
Rota_last

Number of districts in the country 31  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 7 years; Yes
DTwP 2, 3, 5, 18 months; 4 years; Yes
HIB 2, 3, 5, 18 months; Yes
HPV 12 years; +2, +6 months; Yes only females
HepB birth; 1, 6 months; Yes
MMR 12 months; 6 years; Yes
OPV 2, 3.5, 5, 18 months; 7, 14 years; Yes
TT 18 years; Yes
Td 14 years; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  No    Yes  Yes  No 
What years does the MYP cover? number 2012-2020  2012-2020      2010-2015  2010-2015   
Nº of districts with microplans that include activities to raise immunization coverage number 31             

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes         

System performance

Total Nº districts in country number 31  31  31  31  31  31  31 
Nº districts with DTP3 coverage >=80% number 31  31  31  31  31  31 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 30  28  29  29  26  29   
% of districts with MCV1 coverage >=95% From 0 to 100% 97  90  94  94  84  94   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  No  Yes         
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes    Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%     100    100  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.